Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results from a Series of Case-Control Studies

American Journal of Epidemiology

Volumn 181, Issue 12, 2015, Pages 956-969

  Sprague, Brian L ^a   Gangnon, Ronald E ^a   Hampton, John M ^a   Egan, Kathleen M ^a   Titus, Linda J ^a   Kerlikowske, Karla ^a   Remington, Patrick L ^a   Newcomb, Polly A ^a   Trentham Dietz, Amy ^a  

^a NONE

Author keywords

breast neoplasms; case control studies; mammography; mass screening; prevention and control

Indexed keywords

ESTROGEN; GESTAGEN;

CANCER; HEALTH RISK; RISK FACTOR; WOMENS HEALTH;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; PARITY; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTOR; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; EVALUATION STUDY; MASS SCREENING; ODDS RATIO; PROCEDURES; STATISTICAL MODEL;

MASSACHUSETTS; NEW HAMPSHIRE; UNITED STATES; WISCONSIN;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 84931079274     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu474     Document Type: Article

References (40)

1. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528-1540.
2. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer. 2011;117(10):2209-2218.
3. Breen N, Yabroff KR, Meissner HI. What proportion of breast cancers are detected by mammography in the United States? Cancer Detect Prev. 2007;31(3):220-224.
4. Gill PG, Farshid G, Luke CG, et al. Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer. Breast. 2004;13(1):15-22.
5. Dong W, Berry DA, Bevers TB, et al. Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the University of Texas M.D. Anderson Cancer Center experience. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1096-1103.
6. Shen Y, Yang Y, Inoue LY, et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst. 2005;97(16):1195-1203.
7. Wishart GC, Greenberg DC, Britton PD, et al. Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer. 2008;98(11):1741-1744.
8. Joensuu H, Lehtimäki T, Holli K, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004;292(9):1064-1073.
9. Buist DS, Abraham LA, Barlow WE, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat. 2010;124(3):863-873.
10. de Gelder R, Heijnsdijk EA, van Ravesteyn NT, et al. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011;33(1):111-121.
11. Etzioni R, Gulati R, Mallinger L, et al. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med. 2013;158(11):831-838.
12. Marmot MG, Altman DG, Cameron DA, et al. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205-2240.
13. Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310(8):797-798.
14. Joffe MM, Byrne C, Colditz GA. Postmenopausal hormone use, screening, and breast cancer: characterization and control of a bias. Epidemiology. 2001;12(4):429-438.
15. Cook NR, Rosner BA, Hankinson SE, et al. Mammographic screening and risk factors for breast cancer. Am J Epidemiol. 2009;170(11):1422-1432.
16. Newcomb PA, Trentham-Dietz A, Hampton JM, et al. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer. 2011;117(9):1946-1956.
17. Newcomb PA, Storer BE, Longnecker MP, et al. Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med. 1994;330(2):81-87.
18. Titus-Ernstoff L, Egan KM, Newcomb PA, et al. Exposure to breast milk in infancy and adult breast cancer risk. J Natl Cancer Inst. 1998;90(12):921-924.
19. Sprague BL, Trentham-Dietz A, Newcomb PA, et al. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(2):236-243.
20. Nelson SE, Gould MN, Hampton JM, et al. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res. 2005;7(3):R357-R364.
21. Nichols HB, Trentham-Dietz A, Sprague BL, et al. Effects of birth order and maternal age on breast cancer risk: modification by whether women had been breast-fed. Epidemiology. 2008;19(3):417-423.
22. Newcomer LM, Newcomb PA, Trentham-Dietz A, et al. Detection method and breast carcinoma histology. Cancer. 2002;95(3):470-477.
23. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219-242.
24. Munsell MF, Sprague BL, Berry DA, et al. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36(1):114-136.
25. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons, Inc.; 1987.
26. Weiss NS. Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it. Am J Epidemiol. 2003;157(11):957-961.
27. Joffe MM. Invited commentary: screening as a nuisance variable in cancer epidemiology: methodological considerations. Am J Epidemiol. 2003;157(11):962-964.
28. Burke JP, Power C, Gorey TF, et al. A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer. Eur J Surg Oncol. 2008;34(2):149-153.
29. Gross CP, Filardo G, Singh HS, et al. The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview Survey. J Gen Intern Med. 2006;21(2):158-164.
30. Kirsh VA, Chiarelli AM, Edwards SA, et al. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario Breast Screening Program. J Natl Cancer Inst. 2011;103(12):942-950.
31. Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999;91(23):2020-2028.
32. Althuis MD, Fergenbaum JH, Garcia-Closas M, et al. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13(10):1558-1568.
33. Kerlikowske K, Walker R, Miglioretti DL, et al. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst. 2008;100(23):1724-1733.
34. Phipps AI, Buist DS, Malone KE, et al. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control. 2011;22(3):399-405.
35. Banks E, Reeves G, Beral V, et al. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. BMJ. 2004;329(7464):477.
36. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138(3):168-175.
37. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227-236.
38. Vachon CM, Kuni CC, Anderson K, et al. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000;11(7):653-662.
39. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014;106(10):dju255.
40. Oestreicher N, White E, Lehman CD, et al. Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat. 2002;76(1):73-81.